MarketCap
Enlivex Therapeutics Ltd. ENLV
$ 0.36
0.36%
Facebook
X
Telegram
Enlivex Therapeutics Ltd. P/CF Ratio | ENLV
Annual P/CF Ratio Enlivex Therapeutics Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.21 | -1.4 | -1.2 | -1.93 | -6.36 | -11.2 | -10.3 | -6.87 | -27.2 | -1.07 | -3.92 | -22.3 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.07 | -27.2 | -8.17 |
P/CF Ratio of other stocks in the Biotechnology industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Trillium Therapeutics Inc.
TRIL
|
-48.4 | - | - | $ 1.94 B |  Canada |
 |
Urovant Sciences Ltd.
UROV
|
-2.65 K | - | - | $ 532 M |  Britain |
 |
Acceleron Pharma Inc.
XLRN
|
-51.2 | - | - | $ 10.9 B |  USA |
 |
Zealand Pharma A/S
ZEAL
|
-0.706 | - | 0.52 % | $ 821 M |  Danmark |
 |
Zogenix, Inc.
ZGNX
|
-5.69 | - | -4.97 % | $ 664 M | USA |
|
Yunhong International
ZGYH
|
-77.7 | - | 0.10 % | $ 92.2 M |  China |
 |
ZIOPHARM Oncology, Inc.
ZIOP
|
-11.8 | - | -7.58 % | $ 264 M | USA |
 |
Leap Therapeutics
LPTX
|
-1 | - | 368.57 % | $ 41.9 M | USA |
 |
Cortexyme
CRTX
|
-3.83 | - | -1.05 % | $ 67.1 M | USA |
 |
Aptorum Group Limited
APM
|
-3.64 | - | - | $ 5.72 M | China |
 |
FSD Pharma
HUGE
|
-1.79 | - | 5743.5 % | $ 69.7 M | Canada |
 |
BioAtla
BCAB
|
-0.195 | $ 1.74 | 0.64 % | $ 102 M | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
14.6 | - | - | $ 3.85 B | USA |
 |
ARCA biopharma
ABIO
|
-8.36 | - | 1052.0 % | $ 415 M | USA |
 |
Acasti Pharma
ACST
|
-2.73 | - | 4.01 % | $ 150 M | Canada |
 |
ADiTx Therapeutics
ADTX
|
-0.00143 | - | - | $ 374 | USA |
 |
Aeterna Zentaris
AEZS
|
-1.01 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
-11.8 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
-4.6 | - | - | $ 1.01 B | USA |
 |
AIkido Pharma
AIKI
|
-1.17 | - | 1.93 % | $ 17.4 M | USA |
 |
Aileron Therapeutics
ALRN
|
-1.71 | - | 10.36 % | $ 9.8 M | USA |
 |
AlloVir
ALVR
|
-0.632 | - | 4.14 % | $ 49.1 M | USA |
 |
Apellis Pharmaceuticals
APLS
|
61.2 | - | - | $ 5.18 B | USA |
 |
Athira Pharma
ATHA
|
-0.0166 | - | - | $ 269 M | USA |
 |
Avenue Therapeutics
ATXI
|
-0.0603 | - | -52.27 % | $ 4.45 M | USA |
 |
AVROBIO
AVRO
|
-0.0396 | - | 1083.1 % | $ 745 M | USA |
 |
AstraZeneca PLC
AZN
|
9.7 | - | - | $ 96.9 B | Britain |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.696 | - | -2.5 % | $ 5.88 M | USA |
 |
BeiGene, Ltd.
BGNE
|
-1.8 K | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bio-Path Holdings
BPTH
|
-0.733 | - | - | $ 100 K | USA |
 |
Cara Therapeutics
CARA
|
-0.049 | - | -3.03 % | $ 260 M | USA |
 |
ChromaDex Corporation
CDXC
|
35.6 | - | -0.88 % | $ 598 M | USA |
 |
Caladrius Biosciences
CLBS
|
-0.185 | - | -16.75 % | $ 25.8 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-0.000698 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-0.0137 | - | -4.36 % | $ 27 M | USA |
 |
Diffusion Pharmaceuticals
DFFN
|
-1.57 | - | 11.68 % | $ 8.97 M | USA |
 |
Eloxx Pharmaceuticals
ELOX
|
-8.85 | - | -5.68 % | $ 8.28 M | USA |
 |
Enochian Biosciences
ENOB
|
-14.7 | - | - | $ 40.5 M | USA |
 |
Esperion Therapeutics
ESPR
|
-42.9 | - | - | $ 661 M | USA |
 |
Evofem Biosciences
EVFM
|
-0.431 | - | 7.55 % | $ 38.1 M | USA |
 |
Eyenovia
EYEN
|
-0.0265 | - | 49.81 % | $ 13.2 M | USA |
 |
FibroGen
FGEN
|
-0.571 | - | - | $ 889 M | USA |
 |
Homology Medicines
FIXX
|
-0.672 | - | 0.77 % | $ 53.4 M | USA |
 |
Amicus Therapeutics
FOLD
|
134 | - | - | $ 4.47 B | USA |
|
Frequency Therapeutics
FREQ
|
-0.34 | - | - | $ 528 M | USA |
|
Galecto
GLTO
|
-0.0253 | - | - | $ 762 M | Danmark |
 |
GlycoMimetics
GLYC
|
-2.88 | - | 9357.83 % | $ 1.01 B | USA |
 |
Graybug Vision
GRAY
|
-0.0767 | - | -11.23 % | $ 9.65 M | USA |
|
Galera Therapeutics
GRTX
|
-0.63 | - | -32.59 % | $ 7.61 M | USA |
 |
Happiness Biotech Group Limited
HAPP
|
-0.848 | - | 1.35 % | $ 17.8 M | China |